25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SCNX (Scienture) Stock Analysis
Buy, Hold or Sell?

Let's analyze Scienture together

I guess you are interested in Scienture Holdings, Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Scienture’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Scienture’s Price Targets

I'm going to help you getting a better view of Scienture Holdings, Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Scienture Holdings, Inc.

I send you an email if I find something interesting about Scienture Holdings, Inc..

1. Quick Overview

1.1. Quick analysis of Scienture (30 sec.)










1.2. What can you expect buying and holding a share of Scienture? (30 sec.)

How much money do you get?

How much money do you get?
$0.06
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$2.26
Expected worth in 1 year
$4.18
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$1.98
Return On Investment
278.5%

For what price can you sell your share?

Current Price per Share
$0.71
Expected price per share
$0.461 - $2.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Scienture (5 min.)




Live pricePrice per Share (EOD)
$0.71
Intrinsic Value Per Share
$-2.29 - $-1.55
Total Value Per Share
$-0.03 - $0.71

2.2. Growth of Scienture (5 min.)




Is Scienture growing?

Current yearPrevious yearGrowGrow %
How rich?$77.8m$12.1m$68.6m85.0%

How much money is Scienture making?

Current yearPrevious yearGrowGrow %
Making money-$5m$3m-$8.1m-161.4%
Net Profit Margin-12,067.8%-2,675.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Scienture (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Scienture?

Welcome investor! Scienture's management wants to use your money to grow the business. In return you get a share of Scienture.

First you should know what it really means to hold a share of Scienture. And how you can make/lose money.

Speculation

The Price per Share of Scienture is $0.711. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Scienture.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Scienture, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.26. Based on the TTM, the Book Value Change Per Share is $0.48 per quarter. Based on the YOY, the Book Value Change Per Share is $0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Scienture.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.19-27.4%-0.15-20.5%0.0912.6%-0.03-4.0%-0.03-4.4%-0.02-2.6%
Usd Book Value Change Per Share-0.10-13.5%0.4867.4%0.0913.3%0.1825.9%0.1013.8%0.067.9%
Usd Dividend Per Share0.000.0%0.022.2%0.0912.9%0.045.1%0.023.0%0.011.5%
Usd Total Gains Per Share-0.10-13.5%0.5069.6%0.1926.3%0.2230.9%0.1216.8%0.079.4%
Usd Price Per Share1.04-4.03-8.41-5.39-4.87-4.29-
Price to Earnings Ratio-1.33--8.30--19.56--16.27--0.30-15.23-
Price-to-Total Gains Ratio-10.86--4.52--55.74--44.01--57.50-12.00-
Price to Book Ratio0.46-1.69-23.76--13.41-2.53--73.56-
Price-to-Total Gains Ratio-10.86--4.52--55.74--44.01--57.50-12.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.711
Number of shares1406
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.480.10
Usd Total Gains Per Share0.500.12
Gains per Quarter (1406 shares)696.01168.37
Gains per Year (1406 shares)2,784.03673.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18926952774121552663
21785390555824211051336
32688084834236416572009
4357107791112648522092682
5446134741391060627613355
6535161691669472733144028
7625188641947884838664701
8714215582226297044185374
98032425325046109149716047
108922694827830121255236720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%12.028.00.030.0%12.048.00.020.0%
Book Value Change Per Share2.02.00.050.0%5.06.01.041.7%6.013.01.030.0%21.018.01.052.5%28.028.04.046.7%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%2.00.058.03.3%
Total Gains per Share2.02.00.050.0%5.06.01.041.7%6.013.01.030.0%21.018.01.052.5%28.028.04.046.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Scienture Holdings, Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0960.479-120%0.095-201%0.184-152%0.098-198%0.056-271%
Book Value Per Share--2.2592.344-4%0.352+542%0.901+151%0.608+271%0.323+599%
Current Ratio--0.1110.824-86%2.539-96%1.417-92%3.953-97%3.338-97%
Debt To Asset Ratio--0.2530.208+22%0.331-23%0.497-49%0.409-38%0.828-69%
Debt To Equity Ratio--0.3400.271+25%0.559-39%1.273-73%0.987-66%0.949-64%
Dividend Per Share---0.016-100%0.092-100%0.036-100%0.022-100%0.011-100%
Enterprise Value--9434220.200117948149.325-92%286125161.387-97%176451775.925-95%163404701.871-94%161478323.465-94%
Eps---0.195-0.146-25%0.090-317%-0.029-85%-0.031-84%-0.018-91%
Ev To Ebitda Ratio---0.390-7.975+1946%45.466-101%3.898-110%9.030-104%75.573-101%
Free Cash Flow Per Share---0.059-0.096+63%-0.051-14%-0.050-16%-0.035-42%-0.021-65%
Free Cash Flow To Equity Per Share---0.059-0.056-6%-0.150+153%-0.070+18%-0.047-21%-0.019-68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.548----------
Intrinsic Value_10Y_min---2.287----------
Intrinsic Value_1Y_max---0.093----------
Intrinsic Value_1Y_min---0.206----------
Intrinsic Value_3Y_max---0.327----------
Intrinsic Value_3Y_min---0.642----------
Intrinsic Value_5Y_max---0.617----------
Intrinsic Value_5Y_min---1.101----------
Market Cap24511177.530-46%35853199.200138844961.325-74%289896385.637-88%185654932.675-81%168057561.971-79%147728539.468-76%
Net Profit Margin----120.6780%-26.7540%-49.7580%-30.0640%-15.1240%
Operating Margin----99.5340%-22.1420%-41.2480%-24.9570%-12.5300%
Operating Ratio---121.118-100%22.303-100%48.486-100%29.700-100%15.397-100%
Pb Ratio0.315-46%0.4601.695-73%23.764-98%-13.415+3013%2.533-82%-73.565+16076%
Pe Ratio-0.912+32%-1.334-8.296+522%-19.558+1366%-16.269+1120%-0.304-77%15.227-109%
Price Per Share0.711-46%1.0404.028-74%8.409-88%5.385-81%4.875-79%4.285-76%
Price To Free Cash Flow Ratio-3.000+32%-4.389-9.670+120%-47.657+986%29.050-115%2.646-266%9.317-147%
Price To Total Gains Ratio-7.422+32%-10.857-4.517-58%-55.736+413%-44.011+305%-57.498+430%12.000-190%
Quick Ratio--0.0100.728-99%2.268-100%1.241-99%3.311-100%2.762-100%
Return On Assets---0.064-0.049-24%0.205-131%-0.036-45%-0.091+41%-0.111+72%
Return On Equity---0.086-0.063-27%0.199-143%-0.172+99%-0.213+147%-0.159+85%
Total Gains Per Share---0.0960.495-119%0.187-151%0.220-144%0.120-180%0.067-243%
Usd Book Value--77860464.00080806846.500-4%12130931.000+542%31067597.333+151%20969279.750+271%11139908.200+599%
Usd Book Value Change Per Share---0.0960.479-120%0.095-201%0.184-152%0.098-198%0.056-271%
Usd Book Value Per Share--2.2592.344-4%0.352+542%0.901+151%0.608+271%0.323+599%
Usd Dividend Per Share---0.016-100%0.092-100%0.036-100%0.022-100%0.011-100%
Usd Enterprise Value--9434220.200117948149.325-92%286125161.387-97%176451775.925-95%163404701.871-94%161478323.465-94%
Usd Eps---0.195-0.146-25%0.090-317%-0.029-85%-0.031-84%-0.018-91%
Usd Free Cash Flow---2042392.000-3324092.250+63%-1758766.250-14%-1715901.833-16%-1194249.450-42%-709169.425-65%
Usd Free Cash Flow Per Share---0.059-0.096+63%-0.051-14%-0.050-16%-0.035-42%-0.021-65%
Usd Free Cash Flow To Equity Per Share---0.059-0.056-6%-0.150+153%-0.070+18%-0.047-21%-0.019-68%
Usd Market Cap24511177.530-46%35853199.200138844961.325-74%289896385.637-88%185654932.675-81%168057561.971-79%147728539.468-76%
Usd Price Per Share0.711-46%1.0404.028-74%8.409-88%5.385-81%4.875-79%4.285-76%
Usd Profit---6720573.000-5032725.750-25%3090475.750-317%-987501.667-85%-1069179.000-84%-627790.075-91%
Usd Revenue---32050.500-100%788924.750-100%727374.917-100%1673174.800-100%1490473.500-100%
Usd Total Gains Per Share---0.0960.495-119%0.187-151%0.220-144%0.120-180%0.067-243%
 EOD+3 -5MRQTTM+7 -29YOY+11 -253Y+12 -245Y+13 -2310Y+11 -25

3.3 Fundamental Score

Let's check the fundamental score of Scienture Holdings, Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.912
Price to Book Ratio (EOD)Between0-10.315
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.010
Current Ratio (MRQ)Greater than10.111
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.340
Return on Equity (MRQ)Greater than0.15-0.086
Return on Assets (MRQ)Greater than0.05-0.064
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Scienture Holdings, Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.284
Ma 20Greater thanMa 500.868
Ma 50Greater thanMa 1000.857
Ma 100Greater thanMa 2001.219
OpenGreater thanClose0.740
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Scienture Holdings, Inc.

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.

Fundamental data was last updated by Penke on 2025-11-01 04:00:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Scienture earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Scienture Holdings, Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-12,067.8%+12,067.8%
TTM-12,067.8%YOY-2,675.4%-9,392.4%
TTM-12,067.8%5Y-3,006.4%-9,061.4%
5Y-3,006.4%10Y-1,512.4%-1,493.9%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.2%-1.2%
TTM-12,067.8%1.0%-12,068.8%
YOY-2,675.4%1.6%-2,677.0%
3Y-4,975.8%1.6%-4,977.4%
5Y-3,006.4%2.3%-3,008.7%
10Y-1,512.4%1.8%-1,514.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Scienture is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • -6.4% Return on Assets means thatΒ Scienture generatedΒ $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Scienture Holdings, Inc.:

  • The MRQ is -6.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-4.9%-1.6%
TTM-4.9%YOY20.5%-25.4%
TTM-4.9%5Y-9.1%+4.2%
5Y-9.1%10Y-11.1%+2.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.4%0.4%-6.8%
TTM-4.9%0.5%-5.4%
YOY20.5%0.8%+19.7%
3Y-3.6%0.7%-4.3%
5Y-9.1%1.1%-10.2%
10Y-11.1%0.9%-12.0%
4.3.1.3. Return on Equity

Shows how efficient Scienture is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • -8.6% Return on Equity means Scienture generated $-0.09Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Scienture Holdings, Inc.:

  • The MRQ is -8.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-6.3%-2.3%
TTM-6.3%YOY19.9%-26.2%
TTM-6.3%5Y-21.3%+15.0%
5Y-21.3%10Y-15.9%-5.4%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%1.8%-10.4%
TTM-6.3%2.3%-8.6%
YOY19.9%3.2%+16.7%
3Y-17.2%3.0%-20.2%
5Y-21.3%3.3%-24.6%
10Y-15.9%2.9%-18.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Scienture Holdings, Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Scienture is operatingΒ .

  • Measures how much profit Scienture makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Scienture Holdings, Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-9,953.4%+9,953.4%
TTM-9,953.4%YOY-2,214.2%-7,739.2%
TTM-9,953.4%5Y-2,495.7%-7,457.7%
5Y-2,495.7%10Y-1,253.0%-1,242.7%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%-2.4%
TTM-9,953.4%2.1%-9,955.5%
YOY-2,214.2%2.5%-2,216.7%
3Y-4,124.8%2.0%-4,126.8%
5Y-2,495.7%2.9%-2,498.6%
10Y-1,253.0%2.5%-1,255.5%
4.3.2.2. Operating Ratio

Measures how efficient Scienture is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Scienture Holdings, Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM121.118-121.118
TTM121.118YOY22.303+98.815
TTM121.1185Y29.700+91.418
5Y29.70010Y15.397+14.303
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.128-1.128
TTM121.1181.179+119.939
YOY22.3031.004+21.299
3Y48.4861.087+47.399
5Y29.7001.108+28.592
10Y15.3971.155+14.242
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Scienture Holdings, Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Scienture is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Pharmaceutical Retailers industry mean).
  • A Current Ratio of 0.11Β means the company has $0.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Scienture Holdings, Inc.:

  • The MRQ is 0.111. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.824. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.111TTM0.824-0.713
TTM0.824YOY2.539-1.715
TTM0.8245Y3.953-3.128
5Y3.95310Y3.338+0.615
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1111.352-1.241
TTM0.8241.323-0.499
YOY2.5391.282+1.257
3Y1.4171.327+0.090
5Y3.9531.367+2.586
10Y3.3381.497+1.841
4.4.3.2. Quick Ratio

Measures if Scienture is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.01Β means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Scienture Holdings, Inc.:

  • The MRQ is 0.010. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.728. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.010TTM0.728-0.718
TTM0.728YOY2.268-1.541
TTM0.7285Y3.311-2.583
5Y3.31110Y2.762+0.549
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0100.484-0.474
TTM0.7280.505+0.223
YOY2.2680.654+1.614
3Y1.2410.601+0.640
5Y3.3110.648+2.663
10Y2.7620.855+1.907
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Scienture Holdings, Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ScientureΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Scienture to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.25Β means that Scienture assets areΒ financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Scienture Holdings, Inc.:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.208. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.208+0.045
TTM0.208YOY0.331-0.123
TTM0.2085Y0.409-0.200
5Y0.40910Y0.828-0.420
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2530.632-0.379
TTM0.2080.635-0.427
YOY0.3310.639-0.308
3Y0.4970.646-0.149
5Y0.4090.617-0.208
10Y0.8280.592+0.236
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Scienture is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 34.0% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Scienture Holdings, Inc.:

  • The MRQ is 0.340. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.271. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.271+0.069
TTM0.271YOY0.559-0.288
TTM0.2715Y0.987-0.717
5Y0.98710Y0.949+0.038
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3401.225-0.885
TTM0.2711.334-1.063
YOY0.5591.578-1.019
3Y1.2731.681-0.408
5Y0.9871.619-0.632
10Y0.9491.555-0.606
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Scienture generates.

  • Above 15 is considered overpriced butΒ always compareΒ Scienture to theΒ Pharmaceutical Retailers industry mean.
  • A PE ratio of -1.33 means the investor is paying $-1.33Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Scienture Holdings, Inc.:

  • The EOD is -0.912. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.334. Based on the earnings, the company is expensive. -2
  • The TTM is -8.296. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.912MRQ-1.334+0.422
MRQ-1.334TTM-8.296+6.962
TTM-8.296YOY-19.558+11.262
TTM-8.2965Y-0.304-7.992
5Y-0.30410Y15.227-15.531
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-0.91217.701-18.613
MRQ-1.33416.698-18.032
TTM-8.29615.335-23.631
YOY-19.55818.602-38.160
3Y-16.26923.191-39.460
5Y-0.30427.843-28.147
10Y15.22732.991-17.764
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Scienture Holdings, Inc.:

  • The EOD is -3.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.389. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.670. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.000MRQ-4.389+1.388
MRQ-4.389TTM-9.670+5.281
TTM-9.670YOY-47.657+37.987
TTM-9.6705Y2.646-12.316
5Y2.64610Y9.317-6.671
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-3.0005.392-8.392
MRQ-4.3897.097-11.486
TTM-9.6703.296-12.966
YOY-47.65711.143-58.800
3Y29.0507.231+21.819
5Y2.6468.035-5.389
10Y9.3175.470+3.847
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Scienture is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 0.46 means the investor is paying $0.46Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Scienture Holdings, Inc.:

  • The EOD is 0.315. Based on the equity, the company is cheap. +2
  • The MRQ is 0.460. Based on the equity, the company is cheap. +2
  • The TTM is 1.695. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.315MRQ0.460-0.146
MRQ0.460TTM1.695-1.234
TTM1.695YOY23.764-22.069
TTM1.6955Y2.533-0.838
5Y2.53310Y-73.565+76.097
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD0.3151.656-1.341
MRQ0.4601.842-1.382
TTM1.6951.902-0.207
YOY23.7642.048+21.716
3Y-13.4152.232-15.647
5Y2.5332.264+0.269
10Y-73.5653.073-76.638
4.6.2. Total Gains per Share

2.4. Latest News of Scienture Holdings, Inc.

Does Scienture Holdings, Inc. still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Scienture Holdings, Inc. to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-10-24
10:42
Trending tickers: Intel, Ford, Lumen, Scienture and SanofiRead
2025-10-23
16:30
BC-Most Active StocksRead
2025-10-23
14:05
SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbliβ„’ (Losartan Potassium)Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets104,295
Total Liabilities26,434
Total Stockholder Equity77,860
 As reported
Total Liabilities 26,434
Total Stockholder Equity+ 77,860
Total Assets = 104,295

Assets

Total Assets104,295
Total Current Assets857
Long-term Assets103,438
Total Current Assets
Cash And Cash Equivalents 15
Net Receivables 63
Other Current Assets 779
Total Current Assets  (as reported)857
Total Current Assets  (calculated)857
+/-0
Long-term Assets
Property Plant Equipment 46
Goodwill 21,373
Intangible Assets 76,400
Long-term Assets Other 5,085
Long-term Assets  (as reported)103,438
Long-term Assets  (calculated)102,904
+/- 534

Liabilities & Shareholders' Equity

Total Current Liabilities7,688
Long-term Liabilities18,746
Total Stockholder Equity77,860
Total Current Liabilities
Short-term Debt 2,028
Short Long Term Debt 2,515
Accounts payable 3,136
Other Current Liabilities 2,524
Total Current Liabilities  (as reported)7,688
Total Current Liabilities  (calculated)10,203
+/- 2,515
Long-term Liabilities
Long term Debt 1,578
Capital Lease Obligations 31
Long-term Liabilities Other 1,285
Long-term Liabilities  (as reported)18,746
Long-term Liabilities  (calculated)2,894
+/- 15,853
Total Stockholder Equity
Common Stock0
Retained Earnings -48,824
Other Stockholders Equity 126,684
Total Stockholder Equity (as reported)77,860
Total Stockholder Equity (calculated)77,860
+/-0
Other
Capital Stock0
Cash and Short Term Investments 15
Common Stock Shares Outstanding 14,141
Liabilities and Stockholders Equity 104,295
Net Debt 3,593
Net Invested Capital 81,953
Net Working Capital -6,832
Property Plant and Equipment Gross 46
Short Long Term Debt Total 3,609



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-30
> Total Assets 
0
0
13
0
9
2
2
1
1
0
687
1
1
1
0
0
404
0
328
542
1,222
952
1,528
1,353
2,028
1,824
1,436
1,421
337
512
424
532
617
681
712
1,231
2,228
3,299
3,678
5,855
5,571
11,474
11,732
11,854
9,793
9,693
6,896
5,514
5,766
5,840
5,672
4,689
3,710
4,038
3,745
21,654
21,654
16,739
14,849
94,260
104,854
106,359
104,295
104,295106,359104,85494,26014,84916,73921,65421,6543,7454,0383,7104,6895,6725,8405,7665,5146,8969,6939,79311,85411,73211,4745,5715,8553,6783,2992,2281,2317126816175324245123371,4211,4361,8242,0281,3531,5289521,22254232804040011168701122901300
   > Total Current Assets 
0
0
13
0
9
2
2
1
1
0
687
1
1
1
0
0
395
0
321
537
1,218
950
1,527
1,353
524
1,824
1,436
1,349
337
512
424
532
607
671
702
1,221
1,466
1,491
1,952
4,315
3,803
9,795
10,123
10,643
9,221
9,155
6,536
5,189
4,374
3,597
3,347
2,373
2,093
2,386
2,095
5,548
5,548
14,027
12,144
7,256
6,305
7,825
857
8577,8256,3057,25612,14414,0275,5485,5482,0952,3862,0932,3733,3473,5974,3745,1896,5369,1559,22110,64310,1239,7953,8034,3151,9521,4911,4661,2217026716075324245123371,3491,4361,8245241,3531,5279501,21853732103950011168701122901300
       Cash And Cash Equivalents 
0
0
13
0
9
2
2
1
1
0
687
1
1
1
0
0
84
0
70
271
706
335
414
325
79
508
320
95
15
170
103
173
184
190
208
593
870
534
540
3,359
2,872
7,701
4,151
6,648
5,920
5,209
4,520
3,572
3,123
1,871
962
322
1,095
1,194
746
34
34
3,499
7,720
579
308
2,050
15
152,0503085797,7203,49934347461,1941,0953229621,8713,1233,5724,5205,2095,9206,6484,1517,7012,8723,359540534870593208190184173103170159532050879325414335706271700840011168701122901300
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000110000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
266
0
151
185
349
350
417
444
355
452
374
389
299
273
256
253
319
327
325
420
434
729
713
710
792
877
3,544
1,034
1,893
3,018
1,504
1,009
979
1,041
1,019
1,726
630
708
799
2,241
2,241
10,348
3,544
5,816
5,450
5,348
63
635,3485,4505,8163,54410,3482,2412,2417997086301,7261,0191,0419791,0091,5043,0181,8931,0343,54487779271071372943442032532731925325627329938937445235544441735034918515102660000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
84
51
117
114
274
226
-194
388
204
226
23
68
65
105
104
154
169
195
83
166
152
182
82
848
609
1,314
151
458
373
514
216
400
1,239
250
303
358
389
246
246
174
874
853
548
428
779
7794285488538741742462463893583032501,2394002165143734581511,3146098488218215216683195169154104105656823226204388-1942262741141175184020000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
0
6
5
4
3
1
0
1,504
0
0
72
0
0
0
0
10
10
10
10
762
1,808
1,726
1,540
1,769
1,679
1,609
1,211
571
538
360
325
1,392
2,243
2,325
2,316
1,617
1,652
1,650
16,106
16,106
2,712
2,704
87,004
98,548
98,533
103,438
103,43898,53398,54887,0042,7042,71216,10616,1061,6501,6521,6172,3162,3252,2431,3923253605385711,2111,6091,6791,7691,5401,7261,80876210101010000072001,504013456090000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
0
6
5
4
3
1
0
0
0
0
72
0
0
0
0
0
0
0
0
15
839
816
792
933
931
861
463
550
516
338
303
1,332
1,252
1,218
1,168
1,117
1,065
1,011
1,476
1,476
190
182
233
219
204
46
462042192331821901,4761,4761,0111,0651,1171,1681,2181,2521,332303338516550463861931933792816839150000000072000013456090000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
726
726
726
726
726
726
726
726
0
0
0
0
0
0
0
0
0
0
0
5,129
5,129
0
0
7,849
21,373
21,373
21,373
21,37321,37321,3737,849005,1295,12900000000000726726726726726726726726000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500
2,500
2,500
0
0
0
0002,5002,5002,500000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
942
1,058
1,099
0
708
799
9,452
9,452
8,963
0
76,400
76,400
76,400
76,400
76,40076,40076,40076,40008,9639,4529,45279970801,0991,0589420000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
4
0
12
12
20
26
33
36
48,697
61
63
60
0
0
273
0
404
328
554
612
1,081
972
1,761
1,902
2,283
2,847
1,485
1,238
1,060
1,029
929
873
833
905
1,383
2,081
2,338
1,964
1,431
1,837
1,581
1,027
1,114
1,492
1,109
897
1,996
2,953
3,868
3,333
3,367
3,383
5,040
10,094
10,094
3,120
3,063
9,128
25,782
25,196
26,434
26,43425,19625,7829,1283,0633,12010,09410,0945,0403,3833,3673,3333,8682,9531,9968971,1091,4921,1141,0271,5811,8371,4311,9642,3382,0811,3839058338739291,0291,0601,2381,4852,8472,2831,9021,7619721,08161255432840402730060636148,6973633262012120400
   > Total Current Liabilities 
0
0
4
0
12
12
20
26
33
36
48,697
61
63
60
0
0
273
0
404
328
554
612
1,081
972
1,761
1,172
1,339
1,840
1,475
1,238
656
625
525
469
511
683
860
808
1,085
956
521
951
720
535
842
1,238
861
655
926
1,596
2,546
2,061
2,147
2,550
4,263
9,092
9,092
2,951
2,902
5,413
7,907
7,462
7,688
7,6887,4627,9075,4132,9022,9519,0929,0924,2632,5502,1472,0612,5461,5969266558611,2388425357209515219561,0858088606835114695256256561,2381,4751,8401,3391,1721,7619721,08161255432840402730060636148,6973633262012120400
       Short-term Debt 
0
0
0
0
0
0
0
0
19
19
19,333
19
19
19
0
0
19
0
0
0
0
0
323
361
399
437
378
618
771
395
337
303
262
202
182
322
322
219
221
407
87
91
94
57
356
342
316
64
179
342
350
357
364
204
211
5,481
5,481
65
33
326
2,764
2,581
2,028
2,0282,5812,76432633655,4815,481211204364357350342179643163423565794918740722121932232218220226230333739577161837843739936132300000190019191919,333191900000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,230
6,530
0
0
265
2,700
2,515
2,515
2,5152,5152,700265006,5305,2300000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
1
0
1
5
15
21
8
12
12,914
23
23
25
0
0
162
0
202
219
291
376
508
332
220
339
353
577
237
166
153
123
106
93
129
106
401
412
763
398
335
320
272
192
257
366
168
275
477
908
1,195
744
528
516
864
1,329
1,329
953
726
2,904
2,899
3,185
3,136
3,1363,1852,8992,9047269531,3291,3298645165287441,1959084772751683662571922723203353987634124011061299310612315316623757735333922033250837629121920201620025232312,9141282115510100
       Other Current Liabilities 
0
0
3
0
11
7
5
5
5
5
16,450
18
21
16
0
0
91
0
202
109
240
236
249
279
1,141
396
609
646
467
677
166
200
157
174
200
255
138
178
101
151
99
234
350
286
219
519
377
316
270
345
1,001
960
1,250
1,830
3,188
2,283
2,283
1,933
2,143
2,183
2,244
1,696
2,524
2,5241,6962,2442,1832,1431,9332,2832,2833,1881,8301,2509601,001345270316377519219286350234991511011781382552001741572001666774676466093961,1412792492362401092020910016211816,45055557110300
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
729
944
1,007
11
0
404
404
404
404
323
223
523
1,273
1,253
1,008
910
886
861
492
271
254
248
242
1,070
1,356
1,322
1,271
1,220
832
777
1,002
1,002
169
161
3,714
17,875
17,734
18,746
18,74617,73417,8753,7141611691,0021,0027778321,2201,2711,3221,3561,0702422482542714928618869101,0081,2531,2735232233234044044044040111,0079447290000000000000000000000000
> Total Stockholder Equity
0
0
10
0
-3
-10
-19
-26
-32
-36
-48,010
-60
-63
-60
0
0
131
0
-76
214
668
341
447
380
267
-78
-848
-1,426
-1,148
-726
-636
-498
-312
-192
-121
326
845
1,218
1,340
3,891
4,140
9,637
10,151
10,827
8,679
8,202
5,787
4,617
3,770
2,870
1,821
1,399
763
655
-1,295
11,560
11,560
13,619
11,785
85,132
79,072
81,163
77,860
77,86081,16379,07285,13211,78513,61911,56011,560-1,2956557631,3991,8212,8703,7704,6175,7878,2028,67910,82710,1519,6374,1403,8911,3401,218845326-121-192-312-498-636-726-1,148-1,426-848-78267380447341668214-76013100-60-63-60-48,010-36-32-26-19-10-301000
   Common Stock
0
0
0
0
0
0
0
0
0
0
10,416
10
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000010101010,4160000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
19
0
19
19
19
19
19
19
7,684
8
8
8
0
0
2,650
0
3,666
4,308
5,200
5,316
5,477
5,533
5,916
5,943
6,275
6,540
7,261
7,603
7,700
7,762
7,808
7,845
7,896
8,248
8,956
9,204
9,268
11,790
12,536
17,852
18,909
19,446
19,611
19,785
19,948
20,080
20,018
20,083
20,112
20,193
20,483
20,560
20,586
33,090
33,090
38,290
38,290
117,008
118,111
123,266
126,684
126,684123,266118,111117,00838,29038,29033,09033,09020,58620,56020,48320,19320,11220,08320,01820,08019,94819,78519,61119,44618,90917,85212,53611,7909,2689,2048,9568,2487,8967,8457,8087,7627,7007,6037,2616,5406,2755,9435,9165,5335,4775,3165,2004,3083,66602,650008887,68419191919191901900



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue137
Cost of Revenue-131
Gross Profit66
 
Operating Income (+$)
Gross Profit6
Operating Expense-14,707
Operating Income-14,701-14,701
 
Operating Expense (+$)
Research Development2,237
Selling General Administrative12,054
Selling And Marketing Expenses0
Operating Expense14,70714,291
 
Net Interest Income (+$)
Interest Income135
Interest Expense-1,336
Other Finance Cost-0
Net Interest Income-1,200
 
Pretax Income (+$)
Operating Income-14,701
Net Interest Income-1,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,779-10,623
EBIT - interestExpense = -18,779
8,531
10,401
Interest Expense1,336
Earnings Before Interest and Taxes (EBIT)-17,443-17,443
Earnings Before Interest and Taxes (EBITDA)-17,390
 
After tax Income (+$)
Income Before Tax-18,779
Tax Provision--534
Net Income From Continuing Ops-18,244-18,244
Net Income9,066
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,838
Total Other Income/Expenses Net-4,0781,200
 

Technical Analysis of Scienture
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Scienture. The general trend of Scienture is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Scienture's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Scienture Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Scienture Holdings, Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.8 < 2.4980814814815 < 2.6.

The bearish price targets are: 0.461.

Know someone who trades $SCNX? Share this with them.πŸ‘‡

Scienture Holdings, Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Scienture Holdings, Inc.. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Scienture Holdings, Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Scienture Holdings, Inc.. The current macd is -0.05191827.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Scienture price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Scienture. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Scienture price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Scienture Holdings, Inc. Daily Moving Average Convergence/Divergence (MACD) ChartScienture Holdings, Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Scienture Holdings, Inc.. The current adx is 36.56.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Scienture shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Scienture Holdings, Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Scienture Holdings, Inc.. The current sar is 2.21274638.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Scienture Holdings, Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Scienture Holdings, Inc.. The current rsi is 46.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Scienture Holdings, Inc. Daily Relative Strength Index (RSI) ChartScienture Holdings, Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Scienture Holdings, Inc.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Scienture price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Scienture Holdings, Inc. Daily Stochastic Oscillator ChartScienture Holdings, Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Scienture Holdings, Inc.. The current cci is -39.25148809.

Scienture Holdings, Inc. Daily Commodity Channel Index (CCI) ChartScienture Holdings, Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Scienture Holdings, Inc.. The current cmo is -10.02167957.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Scienture Holdings, Inc. Daily Chande Momentum Oscillator (CMO) ChartScienture Holdings, Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Scienture Holdings, Inc.. The current willr is -95.62616822.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Scienture Holdings, Inc. Daily Williams %R ChartScienture Holdings, Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Scienture Holdings, Inc..

Scienture Holdings, Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Scienture Holdings, Inc.. The current atr is 0.21500555.

Scienture Holdings, Inc. Daily Average True Range (ATR) ChartScienture Holdings, Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Scienture Holdings, Inc.. The current obv is 846,136,368.

Scienture Holdings, Inc. Daily On-Balance Volume (OBV) ChartScienture Holdings, Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Scienture Holdings, Inc.. The current mfi is 57.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Scienture Holdings, Inc. Daily Money Flow Index (MFI) ChartScienture Holdings, Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Scienture Holdings, Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-07-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-11-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-11-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Scienture Holdings, Inc. Daily Candlestick Chart
DateCandlestick Pattern
2025-11-11Bullish Engulfing Candle Pattern

6.4. Technical Score

Let's check the technical score of Scienture Holdings, Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.284
Ma 20Greater thanMa 500.868
Ma 50Greater thanMa 1000.857
Ma 100Greater thanMa 2001.219
OpenGreater thanClose0.740
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Scienture with someone you think should read this too:
  • Are you bullish or bearish on Scienture? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Scienture? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Scienture Holdings, Inc.

I send you an email if I find something interesting about Scienture Holdings, Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Scienture Holdings, Inc..

Receive notifications about Scienture Holdings, Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.